vedolizumab,thiopurine
takeda
['vedolizumab', 'congrat', 'vedo', ' vedo', 'ulcerative colitis', 'ibd', 'thio']
#ddw2023 #views #vedolizumab #ulcerativecolitis #ibd congrats aviv pudipeddi presenting as first author the views data in patients with ulcerative colitis treated with vedolizumab and thiopurine. thiopurine withdrawal has adverse consequences for bio-failure and histo activity 
Dr Rupert Leong Sydney gastroentroenterologist endoscopist IBD @dr_rupey https://t.co/2PKVvAhB6L